The most innovative treatments to overcome a high-risk syndrome
Obstructive sleep apnoea-hypopnoea syndrome (SAHOS) constitutes a significant public health problem. Currently, more than 600,000 patients are treated, while the number undiagnosed people is much higher.
Untreated, SAHOS can cause numerous cardiovascular and cerebrovascular complications. It causes a large number of accidents, at work or on the road, and substantially impairs quality of life.
Over the years, knowledge on the mechanisms of the disease and on its behaviour, have considerably evolved, and a greater and greater number of specialists are being mobilised today to prevent and treat SAHOS.
Pulmonologists have been naturally have been naturally placed in the first line, mainly because the reference treatment, which involves ventilation by Continuous Positive Pressure has been shown to be effective. However, ENTs are also directly concerned, since they are often consulted as a priority when a patient experiences snoring problems.
Any doctor who initiates treatment needs to have perfect knowledge of the indications, the side effects, the methods of follow-up and the limits.
The merit of this work is to illuminate, based on solidly and clearly documented references, a disease that is much more extensive and complex than it appears.